The Point of Care Diagnostics Market is segmented by Product Type (Glucose Testing, Hb1Ac Testing. Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Drug of Abuse (DOA) Testing, Urinalysis/Nephrology, Others), End-User Type (Physician Offices and Outpatient Settings, Pharmacy & Retail Clinics, Hospitals, Homecare Settings, Research Laboratories, Others), and Region (North America [The USA, Canada, and Mexico], Europe [Germany, France, The U.K., Russia, and Rest of Europe], Asia-Pacific [China, Japan, India, South Korea, and Rest of Asia-Pacific], and Rest of the World [Brazil, Saudi Arabia, Israel, and Others]).
The Point of Care Diagnostics Market is segmented by Product Type (Glucose Testing, Hb1Ac Testing. Coagulation Testing, Fertility/Pregnancy, Infectious Disease, Cardiac Markers, Thyroid Stimulating Hormone, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Drug of Abuse (DOA)...
